A comparative study of apoptosis and proliferation in germinoma and glioblastoma

Masahiro Mizoguchi, Takanori Inamura, Tadahisa Shono, Kiyonobu Ikezaki, Satoshi Inoha, Shoichiro Ohgami, Masashi Fukui

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Intracranial germinoma has a relatively good prognosis when treated with radiotherapy and chemotherapy, whereas glioblastoma has a poor prognosis irrespective of these treatments. Cell proliferation and cell death are opposing processes in tumor growth, with tumor progression reflecting the balance between proliferating and apoptotic cells. We investigated cell proliferation and cell death using MIB-1 staining and nick-end labeling in 13 germinomas in comparison with 11 glioblastomas. Expression of BAX and Bcl-2, which regulate apoptosis, were studied by immunohistochemistry. Although germinomas showed strong MIB-1 immunostaining similar to that seen in glioblastomas, germinomas included significantly more apoptotic cells. The ratio of apoptotic ratio to MIB-1 labeling index for germinomas was 72.9 ± 36.9 (mean ± SD), a higher, statistically significant ratio as compared with glioblastomas (14.5 ± 11.2; P < 0.01). Furthermore, germinomas showed greater expression of BAX than did glioblastomas, while the expression of Bcl-2 was weak in both tumor types. A comparison of these apoptotic-related proteins showed that immunoreactivity for BAX was relatively higher in germinomas than in glioblastomas (P < 0.01), corresponding well to numerous apoptotic cells identified in germinoma tissues. These findings may account for the prognostic difference between germinoma and glioblastoma in the face of a similar proliferation potential according to MIB-1 immunostaining. The balance between cell proliferation and death should be considered when predicting outcomes in patients with intracranial tumors.

Original languageEnglish
Pages (from-to)96-102
Number of pages7
JournalNeuro-Oncology
Volume2
Issue number2
Publication statusPublished - Apr 1 2000

Fingerprint

Germinoma
Glioblastoma
Apoptosis
Cell Death
Cell Proliferation
Neoplasms
Radiotherapy
Immunohistochemistry
Staining and Labeling
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Mizoguchi, M., Inamura, T., Shono, T., Ikezaki, K., Inoha, S., Ohgami, S., & Fukui, M. (2000). A comparative study of apoptosis and proliferation in germinoma and glioblastoma. Neuro-Oncology, 2(2), 96-102.

A comparative study of apoptosis and proliferation in germinoma and glioblastoma. / Mizoguchi, Masahiro; Inamura, Takanori; Shono, Tadahisa; Ikezaki, Kiyonobu; Inoha, Satoshi; Ohgami, Shoichiro; Fukui, Masashi.

In: Neuro-Oncology, Vol. 2, No. 2, 01.04.2000, p. 96-102.

Research output: Contribution to journalArticle

Mizoguchi, M, Inamura, T, Shono, T, Ikezaki, K, Inoha, S, Ohgami, S & Fukui, M 2000, 'A comparative study of apoptosis and proliferation in germinoma and glioblastoma', Neuro-Oncology, vol. 2, no. 2, pp. 96-102.
Mizoguchi M, Inamura T, Shono T, Ikezaki K, Inoha S, Ohgami S et al. A comparative study of apoptosis and proliferation in germinoma and glioblastoma. Neuro-Oncology. 2000 Apr 1;2(2):96-102.
Mizoguchi, Masahiro ; Inamura, Takanori ; Shono, Tadahisa ; Ikezaki, Kiyonobu ; Inoha, Satoshi ; Ohgami, Shoichiro ; Fukui, Masashi. / A comparative study of apoptosis and proliferation in germinoma and glioblastoma. In: Neuro-Oncology. 2000 ; Vol. 2, No. 2. pp. 96-102.
@article{36108377c94841ed9a68230585927a6e,
title = "A comparative study of apoptosis and proliferation in germinoma and glioblastoma",
abstract = "Intracranial germinoma has a relatively good prognosis when treated with radiotherapy and chemotherapy, whereas glioblastoma has a poor prognosis irrespective of these treatments. Cell proliferation and cell death are opposing processes in tumor growth, with tumor progression reflecting the balance between proliferating and apoptotic cells. We investigated cell proliferation and cell death using MIB-1 staining and nick-end labeling in 13 germinomas in comparison with 11 glioblastomas. Expression of BAX and Bcl-2, which regulate apoptosis, were studied by immunohistochemistry. Although germinomas showed strong MIB-1 immunostaining similar to that seen in glioblastomas, germinomas included significantly more apoptotic cells. The ratio of apoptotic ratio to MIB-1 labeling index for germinomas was 72.9 ± 36.9 (mean ± SD), a higher, statistically significant ratio as compared with glioblastomas (14.5 ± 11.2; P < 0.01). Furthermore, germinomas showed greater expression of BAX than did glioblastomas, while the expression of Bcl-2 was weak in both tumor types. A comparison of these apoptotic-related proteins showed that immunoreactivity for BAX was relatively higher in germinomas than in glioblastomas (P < 0.01), corresponding well to numerous apoptotic cells identified in germinoma tissues. These findings may account for the prognostic difference between germinoma and glioblastoma in the face of a similar proliferation potential according to MIB-1 immunostaining. The balance between cell proliferation and death should be considered when predicting outcomes in patients with intracranial tumors.",
author = "Masahiro Mizoguchi and Takanori Inamura and Tadahisa Shono and Kiyonobu Ikezaki and Satoshi Inoha and Shoichiro Ohgami and Masashi Fukui",
year = "2000",
month = "4",
day = "1",
language = "English",
volume = "2",
pages = "96--102",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - A comparative study of apoptosis and proliferation in germinoma and glioblastoma

AU - Mizoguchi, Masahiro

AU - Inamura, Takanori

AU - Shono, Tadahisa

AU - Ikezaki, Kiyonobu

AU - Inoha, Satoshi

AU - Ohgami, Shoichiro

AU - Fukui, Masashi

PY - 2000/4/1

Y1 - 2000/4/1

N2 - Intracranial germinoma has a relatively good prognosis when treated with radiotherapy and chemotherapy, whereas glioblastoma has a poor prognosis irrespective of these treatments. Cell proliferation and cell death are opposing processes in tumor growth, with tumor progression reflecting the balance between proliferating and apoptotic cells. We investigated cell proliferation and cell death using MIB-1 staining and nick-end labeling in 13 germinomas in comparison with 11 glioblastomas. Expression of BAX and Bcl-2, which regulate apoptosis, were studied by immunohistochemistry. Although germinomas showed strong MIB-1 immunostaining similar to that seen in glioblastomas, germinomas included significantly more apoptotic cells. The ratio of apoptotic ratio to MIB-1 labeling index for germinomas was 72.9 ± 36.9 (mean ± SD), a higher, statistically significant ratio as compared with glioblastomas (14.5 ± 11.2; P < 0.01). Furthermore, germinomas showed greater expression of BAX than did glioblastomas, while the expression of Bcl-2 was weak in both tumor types. A comparison of these apoptotic-related proteins showed that immunoreactivity for BAX was relatively higher in germinomas than in glioblastomas (P < 0.01), corresponding well to numerous apoptotic cells identified in germinoma tissues. These findings may account for the prognostic difference between germinoma and glioblastoma in the face of a similar proliferation potential according to MIB-1 immunostaining. The balance between cell proliferation and death should be considered when predicting outcomes in patients with intracranial tumors.

AB - Intracranial germinoma has a relatively good prognosis when treated with radiotherapy and chemotherapy, whereas glioblastoma has a poor prognosis irrespective of these treatments. Cell proliferation and cell death are opposing processes in tumor growth, with tumor progression reflecting the balance between proliferating and apoptotic cells. We investigated cell proliferation and cell death using MIB-1 staining and nick-end labeling in 13 germinomas in comparison with 11 glioblastomas. Expression of BAX and Bcl-2, which regulate apoptosis, were studied by immunohistochemistry. Although germinomas showed strong MIB-1 immunostaining similar to that seen in glioblastomas, germinomas included significantly more apoptotic cells. The ratio of apoptotic ratio to MIB-1 labeling index for germinomas was 72.9 ± 36.9 (mean ± SD), a higher, statistically significant ratio as compared with glioblastomas (14.5 ± 11.2; P < 0.01). Furthermore, germinomas showed greater expression of BAX than did glioblastomas, while the expression of Bcl-2 was weak in both tumor types. A comparison of these apoptotic-related proteins showed that immunoreactivity for BAX was relatively higher in germinomas than in glioblastomas (P < 0.01), corresponding well to numerous apoptotic cells identified in germinoma tissues. These findings may account for the prognostic difference between germinoma and glioblastoma in the face of a similar proliferation potential according to MIB-1 immunostaining. The balance between cell proliferation and death should be considered when predicting outcomes in patients with intracranial tumors.

UR - http://www.scopus.com/inward/record.url?scp=0034172945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034172945&partnerID=8YFLogxK

M3 - Article

C2 - 11303626

AN - SCOPUS:0034172945

VL - 2

SP - 96

EP - 102

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 2

ER -